NOVAVAX INC Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Novavax Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Novavax Inc Debt-to-equity for the quarter ending June 30, 2024 was -346 %, a 7.01% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -346 +26.1 +7.01% Jun 30, 2024
Q1 2024 -315 +131 +29.3% Mar 31, 2024
Q4 2023 -319 +424 +57% Dec 31, 2023
Q3 2023 -341 +571 +62.6% Sep 30, 2023
Q2 2023 -372 +4.11K +91.7% Jun 30, 2023
Q1 2023 -446 -1.51K -142% Mar 31, 2023
Q4 2022 -743 -1.2K -264% Dec 31, 2022
Q3 2022 -912 -1.14K -495% Sep 30, 2022
Q2 2022 -4.48K -4.69K -2284% Jun 30, 2022
Q1 2022 1.07K +876 +462% Mar 31, 2022
Q4 2021 454 +176 +63% Dec 31, 2021
Q3 2021 231 -2.11K -90.1% Sep 30, 2021
Q2 2021 205 +955 Jun 30, 2021
Q1 2021 190 +436 Mar 31, 2021
Q4 2020 279 +484 Dec 31, 2020
Q3 2020 2.34K +2.56K Sep 30, 2020
Q2 2020 -749 -512 -215% Jun 30, 2020
Q1 2020 -246 +35.1 +12.5% Mar 31, 2020
Q4 2019 -205 +107 +34.2% Dec 31, 2019
Q3 2019 -213 +155 +42.2% Sep 30, 2019
Q2 2019 -238 +192 +44.7% Jun 30, 2019
Q1 2019 -281 +198 +41.3% Mar 31, 2019
Q4 2018 -312 +301 +49.1% Dec 31, 2018
Q3 2018 -368 +593 +61.7% Sep 30, 2018
Q2 2018 -430 +3.25K +88.3% Jun 30, 2018
Q1 2018 -479 -1.77K -137% Mar 31, 2018
Q4 2017 -613 -1.09K -228% Dec 31, 2017
Q3 2017 -961 -1.17K -563% Sep 30, 2017
Q2 2017 -3.68K -3.78K -3786% Jun 30, 2017
Q1 2017 1.29K +1.24K +2664% Mar 31, 2017
Q4 2016 480 +466 +3253% Dec 31, 2016
Q3 2016 208 +196 +1694% Sep 30, 2016
Q2 2016 99.8 +87.8 +731% Jun 30, 2016
Q1 2016 46.7 +34.2 +273% Mar 31, 2016
Q4 2015 14.3 +0.31 +2.21% Dec 31, 2015
Q3 2015 11.6 -1.28 -9.96% Sep 30, 2015
Q2 2015 12 -1.24 -9.37% Jun 30, 2015
Q1 2015 12.5 -3.91 -23.8% Mar 31, 2015
Q4 2014 14 -4.56 -24.6% Dec 31, 2014
Q3 2014 12.9 -8.66 -40.3% Sep 30, 2014
Q2 2014 13.2 -16.6 -55.6% Jun 30, 2014
Q1 2014 16.4 -11.5 -41.3% Mar 31, 2014
Q4 2013 18.6 -9.24 -33.2% Dec 31, 2013
Q3 2013 21.5 -5.42 -20.1% Sep 30, 2013
Q2 2013 29.9 +5.09 +20.6% Jun 30, 2013
Q1 2013 27.9 +3.93 +16.4% Mar 31, 2013
Q4 2012 27.8 Dec 31, 2012
Q3 2012 26.9 Sep 30, 2012
Q2 2012 24.8 Jun 30, 2012
Q1 2012 24 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.